above the past decade there has bee...

above the past decade there has been a growing disturb among regulatory authorities and pediatricians regarding the labeling of medicines and prescription practices in child health care. Clinical trials in children were largely avoided because of the general vulnerability of children and their inability to provide completely informed consent. Pediatricians and general practitioners were, and still are, oftentimes in the position of having to adapt medicines studied exclusively in adults for use in their child patients. This special issue of ACT is devot to addressing the wants of children ...